跳至主要内容
临床试验/CTRI/2017/07/009084
CTRI/2017/07/009084招募中未知

Impact of a Nutritional supplement on Bone turnover markers in Indian healthy premenopausal women (25-45 yrs; inclusive) after 6 months of intervention: a randomised double blind controlled trial.

GlaxoSmithKline Consumer Healthcare GSKCH0 个研究点目标入组 135 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
135

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Demonstrates understanding of the study procedures restrictions and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form
  • Female Participants
  • Good general and mental health with in the opinion of the investigator or medically qualified designee no clinically significant and relevant abnormalities in medical history or upon physical examination
  • BMI between 18.0 to 30 Kilograms Per Meter Square) inclusive
  • Women who understand willing able and likely to comply with all study procedures and restrictions

排除标准

  • Pregnant women or who are intending to become pregnant over the duration of the study, Women who have attained physiological menopause, Women who are breast-feeding Current or regular use of any prescription, over the counter (OTC), vitamin supplements herbal medicine, Treatment with bisphosphonates or other medications known to affect bone, History of metabolic bone disease, hormonal disorders or disturbances, Bone fracture, intolerance or hypersensitivity to the study materials, Lactose intoletrance, Participation in another clinical study, Previous participation in this study, history of alcohol or other substance abuse, Smoker, Currently taking any other health food drinks/beverages or supplements, Women who used medication known to influence bone mass and the use of calcium, vitamin D, and multivitamin supplements on a regular basis were stopped 2 months before the onset of the trial. Ongoing conditions known to cause abnormalities of calcium metabolism or skeletal health, malabsorption syndromes (such as coeliac or Crohnâ??s disease), hyperthyroidism, hyperparathyroidism, hypo- or hypercalcaemia, osteomalacia, Pagetâ??s disease, and diabetes, Fracture in the past 12 months, chronic kidney disease, obesity, Severely anemic , Undertaking excessive exercise Contraceptive injections within the previous year, Known histories of surgeries such as bilateral oophrectomy (surgical removal of ovaries), Diagnosed hypogondal states such as Turner syndrome, Klinfelter syndrome, Kallman ,syndrome, anorexia nervosa, hypothalamic amenorrhea or hyperprolactinemia, Hemotological disorders, Rheumatological and autoimmune disorders, Miscellaneous conditions and diseases

研究者

发起方
GlaxoSmithKline Consumer Healthcare GSKCH

相似试验